Terms: = Liver cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Clinical Outcome
10 results:
1. Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.
Demir S; Razizadeh N; Indersie E; Branchereau S; Cairo S; Kappler R
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285887
[TBL] [Abstract] [Full Text] [Related]
2. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
[TBL] [Abstract] [Full Text] [Related]
3. 3-Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma.
Li M; Song X; Jin Q; Chen Y; Zhang J; Gao J; Cen L; Lin Y; Xu C; He X; Li Y; Yu C
Liver Int; 2022 May; 42(5):1173-1184. PubMed ID: 35243746
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of Combined VEGFR1-3, PDGFα/β, and fgfr1-3 Blockade Using Nintedanib for Esophagogastric cancer.
Won E; Basunia A; Chatila WK; Hechtman JF; Chou JF; Ku GY; Chalasani SB; Boyar MS; Goldberg Z; Desai AM; Tuvy Y; Berger MF; Tang L; Kelsen DP; Schattner M; Ilson DH; Capanu M; Solit DB; Schultz N; Janjigian YY
Clin Cancer Res; 2019 Jul; 25(13):3811-3817. PubMed ID: 30952642
[TBL] [Abstract] [Full Text] [Related]
5. High expression of B7‑H2 or B7‑H3 is associated with poor prognosis in hepatocellular carcinoma.
Zheng Y; Liao N; Wu Y; Gao J; Li Z; Liu W; Wang Y; Li M; Li X; Chen L; Zhang W; Zhao B
Mol Med Rep; 2019 May; 19(5):4315-4325. PubMed ID: 30942404
[TBL] [Abstract] [Full Text] [Related]
6. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q
Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719
[TBL] [Abstract] [Full Text] [Related]
7. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis.
Takano M; Shimada K; Fujii T; Morita K; Takeda M; Nakajima Y; Nonomura A; Konishi N; Obayashi C
BMC Cancer; 2016 Nov; 16(1):903. PubMed ID: 27863477
[TBL] [Abstract] [Full Text] [Related]
8. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
[TBL] [Abstract] [Full Text] [Related]
9. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract] [Full Text] [Related]
10. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.
Roth TJ; Sheinin Y; Lohse CM; Kuntz SM; Frigola X; Inman BA; Krambeck AE; McKenney ME; Karnes RJ; Blute ML; Cheville JC; Sebo TJ; Kwon ED
Cancer Res; 2007 Aug; 67(16):7893-900. PubMed ID: 17686830
[TBL] [Abstract] [Full Text] [Related]
